These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2832171)

  • 1. New thiol inhibitors of Clostridium histolyticum collagenase. Importance of the P3' position.
    Yiotakis A; Hatgiyannacou A; Dive V; Toma F
    Eur J Biochem; 1988 Mar; 172(3):761-6. PubMed ID: 2832171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New thiol inhibitor of Achromobacter iophagus collagenase. Specificity of the enzyme's S3' subsite.
    Yiotakis A; Dive V
    Eur J Biochem; 1986 Oct; 160(2):413-8. PubMed ID: 3021459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium histolyticum collagenase: development of new thio ester, fluorogenic, and depsipeptide substrates and new inhibitors.
    Vencill CF; Rasnick D; Crumley KV; Nishino N; Powers JC
    Biochemistry; 1985 Jun; 24(13):3149-57. PubMed ID: 2992578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Clostridium histolyticum collagenases by phosphonamide peptide inhibitors.
    Dive V; Yiotakis A; Nicolaou A; Toma F
    Eur J Biochem; 1990 Aug; 191(3):685-93. PubMed ID: 2167850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoramidate peptide inhibitors of human skin fibroblast collagenase.
    Kortylewicz ZP; Galardy RE
    J Med Chem; 1990 Jan; 33(1):263-73. PubMed ID: 2153207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of collagenase from Clostridium histolyticum by phosphoric and phosphonic amides.
    Galardy RE; Grobelny D
    Biochemistry; 1983 Sep; 22(19):4556-61. PubMed ID: 6313042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of beta-collagenase from Clostridium histolyticum.
    Steinbrink DR; Bond MD; Van Wart HE
    J Biol Chem; 1985 Mar; 260(5):2771-6. PubMed ID: 2982835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde and ketone substrate analogues inhibit the collagenase of Clostridium histolyticum.
    Grobelny D; Galardy RE
    Biochemistry; 1985 Oct; 24(22):6145-52. PubMed ID: 3002433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of hydrolysis of collagen-like peptides by class I and class II Clostridium histolyticum collagenases: evidence for both endopeptidase and tripeptidylcarboxypeptidase activities.
    Mookhtiar KA; Steinbrink DR; Van Wart HE
    Biochemistry; 1985 Nov; 24(23):6527-33. PubMed ID: 3002446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ketone cinnamoyl-(1-13C-Phe)-CGly-Pro-Pro is a tetrahedral transition state analog inhibitor of C. histolyticum collagenase.
    Grobelny D; Teater C; Galardy RE
    Biochem Biophys Res Commun; 1989 Mar; 159(2):426-31. PubMed ID: 2539108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketone-substrate analogues of Clostridium histolyticum collagenases: tight-binding transition-state analogue inhibitors.
    Mookhtiar KA; Grobelny D; Galardy RE; Van Wart HE
    Biochemistry; 1988 Jun; 27(12):4299-304. PubMed ID: 2844227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R,S)-mercaptomethyl]-4-methylpentanoic acid.
    Darlak K; Miller RB; Stack MS; Spatola AF; Gray RD
    J Biol Chem; 1990 Mar; 265(9):5199-205. PubMed ID: 2156864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
    Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary substrate specificities of class I and class II collagenases from Clostridium histolyticum.
    Van Wart HE; Steinbrink DR
    Biochemistry; 1985 Nov; 24(23):6520-6. PubMed ID: 3002445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties.
    Scozzafava A; Supuran CT
    Bioorg Med Chem; 2000 Mar; 8(3):637-45. PubMed ID: 10732980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free fatty acids inhibit the activity of Clostridium histolyticum collagenase and human neutrophil elastase.
    Rennert B; Melzig MF
    Planta Med; 2002 Sep; 68(9):767-9. PubMed ID: 12357383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory action of methysergide bimaleate on the collagenase of Clostridium histolyticum].
    Warter A; Schirardin H; Warter J
    C R Seances Soc Biol Fil; 1987; 181(4):415-9. PubMed ID: 2830001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid determination of substrate specificity of Clostridium histolyticum beta-collagenase using an immobilized peptide library.
    Hu Y; Webb E; Singh J; Morgan BA; Gainor JA; Gordon TD; Siahaan TJ
    J Biol Chem; 2002 Mar; 277(10):8366-71. PubMed ID: 11724807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of clostridium histolyticum collagenase.
    Supuran CT; Briganti F; Mincione G; Scozzafava A
    J Enzyme Inhib; 2000; 15(2):111-28. PubMed ID: 10938538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.